Clusterin negatively modulates mechanical stress-mediated ligamentum flavum hypertrophy through TGF-β1 signaling
2
조회
0
다운로드
1
인용
0
참고문헌
초록
Ligamentum flavum hypertrophy (LFH) is a major cause of lumbar spinal canal stenosis (LSCS). The pathomechanisms for LFH have not been fully elucidated. Isobaric tags for relative and absolute quantitation (iTRAQ) technology, proteomics assessments of human ligamentum flavum (LF), and successive assays were performed to explore the effect of clusterin (CLU) upregulation on LFH pathogenesis. LFH samples exhibited higher cell positive rates of the CLU, TGF-β1, α-SMA, ALK5 and p-SMAD3 proteins than non-LFH samples. Mechanical stress and TGF-β1 initiated CLU expression in LF cells. Notably, CLU inhibited the expression of mechanical stress-stimulated and TGF-β1-stimulated COL1A2 and α-SMA. Mechanistic studies showed that CLU inhibited mechanical stress-stimulated and TGF-β1-induced SMAD3 activities through suppression of the phosphorylation of SMAD3 and by inhibiting its nuclear translocation by competitively binding to ALK5. PRKD3 stabilized CLU protein by inhibiting lysosomal distribution and degradation of CLU. CLU attenuated mechanical stress-induced LFH in vivo. In summary, the findings showed that CLU attenuates mechanical stress-induced LFH by modulating the TGF-β1 pathways in vitro and in vivo. These findings imply that CLU is induced by mechanical stress and TGF-β1 and inhibits LF fibrotic responses via negative feedback regulation of the TGF-β1 pathway. These findings indicate that CLU is a potential treatment target for LFH.
Abstract
Ligamentum flavum hypertrophy (LFH) is a major cause of lumbar spinal canal stenosis (LSCS). The pathomechanisms for LFH have not been fully elucidated. Isobaric tags for relative and absolute quantitation (iTRAQ) technology, proteomics assessments of human ligamentum flavum (LF), and successive assays were performed to explore the effect of clusterin (CLU) upregulation on LFH pathogenesis. LFH samples exhibited higher cell positive rates of the CLU, TGF-β1, α-SMA, ALK5 and p-SMAD3 proteins than non-LFH samples. Mechanical stress and TGF-β1 initiated CLU expression in LF cells. Notably, CLU inhibited the expression of mechanical stress-stimulated and TGF-β1-stimulated COL1A2 and α-SMA. Mechanistic studies showed that CLU inhibited mechanical stress-stimulated and TGF-β1-induced SMAD3 activities through suppression of the phosphorylation of SMAD3 and by inhibiting its nuclear translocation by competitively binding to ALK5. PRKD3 stabilized CLU protein by inhibiting lysosomal distribution and degradation of CLU. CLU attenuated mechanical stress-induced LFH in vivo. In summary, the findings showed that CLU attenuates mechanical stress-induced LFH by modulating the TGF-β1 pathways in vitro and in vivo. These findings imply that CLU is induced by mechanical stress and TGF-β1 and inhibits LF fibrotic responses via negative feedback regulation of the TGF-β1 pathway. These findings indicate that CLU is a potential treatment target for LFH.
참고문헌 (39)
- Andersson, G. B., "Epidemiological features of chronic low-back pain", Lancet, 354, pp.581~585 (1999)
- Lu, Q., "Macrophage migration inhibitory factor may contribute to hypertrophy of lumbar ligamentum flavum in type 2 diabetes mellitus", Chin. Med. J. (Engl. ), 133, pp.623~625 (2020)
- Cheung, P. W. H., "The paradoxical relationship between ligamentum flavum hypertrophy and developmental lumbar spinal stenosis", Scoliosis Spinal Disord, 11, pp.26~ (2016)
- Sun, C., "Leptin-induced inflammation by activating IL-6 expression contributes to the fibrosis and hypertrophy of ligamentum flavum in lumbar spinal canal stenosis", Biosci. Rep, 38, pp.1~11 (2018)
- Sun, C., "Ligamentum flavum fibrosis and hypertrophy : molecular pathways, cellular mechanisms, and future directions", FASEB J, 34, pp.9854~9868 (2020)
- Zheng, Z., "CRLF1 is a key regulator in the ligamentum flavum hypertrophy", Front. Cell. Dev. Biol, 8, pp.858~ (2020)
- Toyomi Yoshiiwa, "Analysis of the Relationship between Ligamentum Flavum Thickening and Lumbar Segmental Instability, Disc Degeneration, and Facet Joint Osteoarthritis in Lumbar Spinal Stenosis", Asian Spine Journal, 10(6), pp.1132~1140 (2016), 대한척추외과학회
- Hur, J. W., "The mechanism of ligamentum flavum hypertrophy: introducing angiogenesis as a critical link that couples mechanical stress and hypertrophy", Neurosurgery, 77, pp.274~282 (2015)
- Sairyo, K., "Pathomechanism of ligamentum flavum hypertrophy : a multidisciplinary investigation based on clinical, biomechanical, histologic, and biologic assessments", Spine, 30, pp.2649~2656 (2005)
- Nakatani, T., "Mechanical stretching force promotes collagen synthesis by cultured cells from human ligamentum flavum via transforming growth factor-β1", J. Orthop. Res, 20, pp.1380~1386 (2002)
- Jung, G., "Clusterin attenuates the development of renal fibrosis", J. Am. Soc. Nephrol, 23, pp.73~85 (2012)
- Seo, H. Y., "Clusterin attenuates hepatic fibrosis by inhibiting hepatic stellate cell activation and downregulating the Smad3 signaling pathway", Cells, 8, pp.1442~ (2019)
- Konrad, L., "Analysis of clusterin and clusterin receptors in the endometrium and clusterin levels in cervical mucus of endometriosis", Reprod. Sci, 23, pp.1371~1380 (2016)
- Bass-Stringer, "Clusterin is regulated by IGF1–PI3K signaling in the heart : implications for biomarker and drug target discovery, and cardiotoxicity", Arch. Toxicol, 94, pp.1763~1768 (2020)
- Ha, J., "Plasma clusterin as a potential link between diabetes and Alzheimer disease", J. Clin. Endocrinol. Metab, 105, pp.3058~3068 (2020)
- Cipollari, E., "Correlates and predictors of cerebrospinal fluid cholesterol efflux capacity from neural cells, a family of biomarkers for cholesterol epidemiology in Alzheimer’s disease", J. Alzheimers Dis, 74, pp.563~578 (2020)
- Kadam, R., "Novel nucleolar localization of clusterin and its associated functions in human oral cancers : An in vitro and in silico analysis", Cell Biochem. Funct, 39, pp.380~391 (2021)
- Chen, Z., "Inactivation of tumor suppressor gene clusterin leads to hyperactivation of TAK1-NF-κB signaling axis in lung cancer cells and denotes a therapeutic opportunity", Theranostics, 10, pp.11520~11534 (2020)
- Saito, T., "Experimental mouse model of lumbar ligamentum flavum hypertrophy", PLoS One, 12, pp.e169717~ (2017)
- de Retana, S. F., "Peripheral administration of human recombinant ApoJ", clusterin modulates brain beta-amyloid levels in APP23 mice, 2019, pp.11, 42~
- Reddy, K. B., "Interaction of transforming growth factor β receptors with apolipoprotein J", Clusterin, 1996, pp.35, 309~314
- Manasanch, E. E., "Proteasome inhibitors in cancer therapy", Nat. Rev. Clin. Oncol, 14, pp.417~433 (2017)
- Amaravadi, R., "Recent insights into the function of autophagy in cancer", Genes Dev, 30, pp.1913~1930 (2016)
- Zhao, Y. G., "Autophagosome maturation: an epic journey from the ER to lysosomes", J. Cell Biol, 218, pp.757~770 (2019)
- Löffler, M. C., "Protein kinase D1 deletion in adipocytes enhances energy dissipation and protects against adiposity", Embo J, 37, pp.1~19 (2018)
- Sidon, E., "Molecular profile of ultrastructure changes of the ligamentum flavum related to lumbar spinal canal stenosis", J. Cell Biochem, 120, pp.11716~11725 (2019)
- Liu, C., "Molecular basis of degenerative spinal disorders from a proteomic perspective(Review)", Mol. Med. Rep, 21, pp.9~19 (2019)
- Jezek, J., "The role of vascularization on changes in ligamentum flavum mechanical properties and development of hypertrophy in patients with lumbar spinal stenosis", Spine J, 20, pp.1125~1133 (2020)
- Ao, X., "Development and characterization of a novel bipedal standing mouse model of intervertebral disc and facet joint degeneration", Clin. Orthop. Rel. Res, 477, pp.1492~1504 (2019)
- Abbas, J., "Socioeconomic and physical characteristics of individuals with degenerative lumbar spinal stenosis", Spine (Philos. Pa 1976), 38, pp.E554~E561 (1976)
- Ungefroren, H., "RAC1B suppresses TGF-β1-dependent cell migration in pancreatic carcinoma cells through inhibition of the TGF-β type I receptor ALK5", Cancers, 11, pp.691~ (2019)
- Baarends, W. M., "A novel member of the transmembrane serine", threonine kinase receptor family is specifically expressed in the gonads and in mesenchymal cells adjacent to the mullerian duct, 1994, pp.120, 189~197
- Ye, S., "CCN5 reduces ligamentum flavum hypertrophy by modulating the TGF-β pathway", J. Orthop. Res, 37, pp.2634~2644 (2019)
- Yan, B., "Locally produced IGF-1 promotes hypertrophy of the ligamentum flavum via the mTORC1 signaling pathway", Cell. Physiol. Biochem, 48, pp.293~303 (2018)
- Mori, T., "MicroRNA transcriptome analysis on hypertrophy of ligamentum flavum in patients with lumbar spinal stenosis", Spine Surg. Relat. Res, 1, pp.211~217 (2017)
- Zhang, S., "Deletion of protein kinase D3 promotes liver fibrosis in mice", Hepatology, 72, pp.1717~1734 (2020)
- Liu, Y., "Inhibition lysosomal degradation of clusterin by protein kinase D3 promotes triple-negative breast cancer tumor growth", Adv. Sci, 8, pp.2003205~ (2021)
- Tarquini, C., "Clusterin exerts a cytoprotective and antioxidant effect in human osteoarthritic cartilage", Aging, 12, pp.10129~10146 (2020)
- Pucci, S., "Clusterin silencing restores myoblasts viability and down modulates the inflammatory process in osteoporotic disease", J. Transl. Med, 17, pp.118~ (2019)